Cerebral phosphorus metabolite and transverse relaxation time abnormalities in heroin-dependent subjects at onset of methadone maintenance treatment

Psychiatry Research - Neuroimaging

Volumn 131, Issue 3, 2004, Pages 217-226

  Silveri, Marisa M ^a   Pollack, Mark H ^b   Diaz, Claudia I ^c   Nassar, Leanne E ^a   Mendelson, Jack H ^a   Yurgelun Todd, Deborah A ^a   Renshaw, Perry F ^a   Kaufman, Marc J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c NONE

Author keywords

31P MRS; Heroin; Methadone maintenance; PCr; Phospholipids; T2 RT

Indexed keywords

CREATINE PHOSPHATE; DIAMORPHINE; METHADONE; ORGANOPHOSPHATE; PHOSPHORUS 31;

ADULT; AGE; ARTICLE; BASAL GANGLION; BIOENERGY; BRAIN LEVEL; BRAIN METABOLISM; BRAIN PERFUSION; BRAIN TISSUE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; HEALTH PROGRAM; HEROIN DEPENDENCE; HUMAN; MAINTENANCE THERAPY; METABOLITE; NEUROCHEMISTRY; OBSERVATION; OCCIPITAL CORTEX; ORBITAL CORTEX; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RELAXATION TIME; STEADY STATE;

ADENOSINE TRIPHOSPHATE; ADULT; BASAL GANGLIA; CEREBRAL CORTEX; CROSS-SECTIONAL STUDIES; ENERGY METABOLISM; FEMALE; HEROIN DEPENDENCE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METHADONE; NARCOTICS; PHOSPHOCREATINE; PHOSPHOLIPIDS; PHOSPHORUS; REGIONAL BLOOD FLOW; SUBSTANCE ABUSE DETECTION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 4744373993     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2004.05.003     Document Type: Article

References (41)

1. Anderson C.M., Lowen S.B., Renshaw P.F., Kaufman M.J., Teicher M.H. Non-invasive T2-relaxation time measures correlate with gadolinium-based cerebral blood volume estimates in the putamen and cerebellar vermis of young adults. Society for Neuroscience. 26:2000;1730. (abstract)
2. 31P MR spectroscopy study. Magnetic Resonance in Medicine. 35:1996;658-663
3. Condelli W.S., Dunteman G.H. Exposure to methadone programs and heroin use. American Journal of Drug and Alcohol Abuse. 19:1993;65-78
4. Curran H.V., Kleckham J., Bearn J., Strang J., Wanigaratne S. Effects of methadone on cognition, mood and craving in detoxifying opiate addicts: a dose-response study. Psychopharmacology. 154:2001;153-160
5. Danos P., Kasper S., Grunwald F., Klemm E., Krappel C., Broich K., Hoflich G., Overbeck B., Biersack H.J., Möller H.J. Pathological regional cerebral blood flow in opiate-dependent patients during withdrawal: a HMPAO-SPECT study. Neuropsychobiology. 37:1998;194-199
6. Dursteler-MacFarland K.M., Stormer R., Seifritz E., Hug I., Müller-Spahn F., Ladewig D., Stohler R. Opioid-associated effects on oxygen saturation. Addiction. 95:2000;285-287
7. 31P MRS study. Alcoholism, Clinical and Experimental Research. 25:2001;89-97
8. Galynker I.I, Watras-Ganz S., Miner C., Rosenthal R.N., Des Jarlais D.C., Richman B.L., London E. Cerebral metabolism in opiate-dependent subjects: effects of methadone maintenance. Mount Sinai Journal of Medicine. 67:2000;381-387
9. Goldstein M.F., Deren S., Beardsley M., Richman B.L. An alternative program for methadone maintenance dropouts: description and preliminary data. Mount Sinai Journal of Medicine. 68:2001;33-40
10. 2 on cerebral blood volume, blood flow, and vascular mean transit time. Stroke. 5:1974;630-639
11. Gruber S.A., Silveri M.M., Tzilos G.K., Pollack M., Renshaw P.F., Kaufman M.J., Yurgelun-Todd D.A. Methadone maintenance improves cognitive performance after two months of treatment. College on Problems of Drug Dependence. 61:2003;. (abstract)
12. Haselhorst R., Dursteler-MacFarland K.M., Scheffler K., Ladewig D., Müller-Spahn F., Stohler R., Seelig J., Seifritz E. Frontocortical N-acetylaspartate reduction associated with long-term IV heroin use. Neurology. 58:2002;305-307
13. Holtzman D., Mulkern R., Meyers R., Cook C., Allred E., Khait I., Jensen F., Tsuji M., Laussen P. In vivo phosphocreatine and ATP in piglet cerebral gray and white matter during seizures. Brain Research. 783:1998;19-27
14. Howe R.C., Hegge F.W., Phillips J.L. Acute heroin abstinence in man: I. Changes in behavior and sleep. Drug and Alcohol Dependence. 5:1980;341-356
15. Joe G.W., Simpson D.D., Greener J.M., Rowan-Szal G.A. Integrative modeling of client engagement and outcomes during the first 6 months of methadone treatment. Addictive Behaviors. 24:1999;649-659
16. Joseph H., Stancliff S., Langrod J. Methadone maintenance treatment (MMT): a review of historical and clinical issues. Mount Sinai Journal of Medicine. 67:2000;347-364
17. Kaufman M.J., Pollack M.H., Villafuerte R.A., Kukes T.J., Rose S.L., Mendelson J.H., Cohen B.M., Renshaw P.F. Cerebral phosphorus metabolite abnormalities in opiate-dependent polydrug abusers in methadone maintenance. Psychiatry Research: Neuroimaging. 90:1999;143-152
18. Klunk W.E., Xu C.J., Panchalingam K., McClure R.J., Pettegrew J.W. Analysis of magnetic resonance spectra by mole percent: comparison to absolute units. Neurobiology of Aging. 15:1994;133-140
19. Kreek M.J. Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. Annals of the New York Academy of Sciences. 909:2000;186-216
20. Kreek M.J., Reisinger M. The addict as patient. Lowinson J.H., Ruiz P., Millman R.B., Langrod J. Substance Abuse: A Comprehensive Textbook. 1997;822-823 Williams and Wilkins, Baltimore
21. Krystal J.H., Woods S.W., Kosten T.R., Rosen M.I., Seibyl J.P., van Dyck C.C., Price L.H., Zubal I.G., Hoffer P.B., Charney D.S. Opiate dependence and withdrawal: preliminary assessment using single photon emission computerized tomography (SPECT). American Journal of Drug and Alcohol Abuse. 21:1995;47-63
22. Kunz-Schughart L.A., Freyer J.P. Phosphorous metabolites and steady-state energetics of transformed fibroblasts during three-dimensional growth. American Journal of Physiology. Cell Physiology. 283:2002;C1287-C1297
23. Levin J.M., Holman B.L., Mendelson J.H., Teoh S.K., Garada B., Johnson K.A., Springer S. Gender differences in cerebral perfusion in cocaine abuse: technetium-99 m-HMPAO SPECT study of drug-abusing women. Journal of Nuclear Medicine. 35:1994;1902-1909
24. Levin J.M., Mendelson J.H., Holman B.L., Teoh S.K., Garada B., Schwartz R.B., Mello N.K. Improved regional cerebral blood flow in chronic cocaine polydrug users treated with buprenorphine. Journal of Nuclear Medicine. 36:1995;1211-1215
25. Lim K.O., Pauly J., Webb P., Hurd R., Macovski A. Short TE phosphorus spectroscopy using a spin-echo pulse. Magnetic Resonance in Medicine. 32:1994;98-103
26. London E., Margolin R.A., Wong D.F., Links J., La France N.D., Cascella N.G., Broussolle E.P., Wagner H.N. Jr., Snyder F.R., Jasinski D.R. Cerebral glucose utilization in human heroin addicts: case reports from a positron emission tomographic study. Research Communications in Substance Abuse. 10:1989;141-144
27. MacKay S., Meyerhoff D.J., Dillon W.P., Weiner M.W., Fein G. Alteration of brain phospholipid metabolites in cocaine-dependent polysubstance abusers. Biological Psychiatry. 34:1993;261-264
28. McLellan A.T., Luborsky L., Cacciola J., Griffith J., McGahan P., O'Brien C.P. Guide to the Addiction Severity Index: Background, Administration, and Field Testing Results. 1985;National Institute on Drug Abuse, Rockville, MD
29. Meyerhoff D.J., MacKay S., Sappey-Marinier D., Deicken R., Calabrese G., Dillon W.P., Weiner M.W., Fein G. Effects of chronic alcohol abuse and HIV infection on brain phosphorus metabolites. Alcoholism, Clinical and Experimental Research. 19:1995;685-692
30. NIDA Highlights and Executive Summary, Community Epidemiology Work Group. Epidemiologic Trends in Drug Abuse. vol. 1:2000;Superintendent of Documents, U.S. Government Printing Office, Washington, DC
31. Rose J.S., Branchey M., Buydens-Branchey L., Stapleton J.M., Chasten K., Werrell A., Maayan M.L. Cerebral perfusion in early and late opiate withdrawal: a technetium-99m-HMPAO SPECT study. Psychiatry Research: Neuroimaging. 67:1996;39-47
32. SAMHSA, 2001. Emergency Department Trends from the Drug Abuse Warning Network, Preliminary Estimates January-June 2001 with Revised Estimates 1994-2000, DAWN Series D-20, DHHS Publication No. (SMA) 02-3634, Rockville, MD.
33. Santolaria-Fernandez F.J., Gomez-Sirvent J.L., Gonzalez-Reimers C.L., Batista-Lopez J.N., Jorge-Hernandez J.A., Rodriguez-Moreno F., Martinez-Riera A., Hernandez-Garcia M.T. Nutritional assessment of drug addicts. Drug and Alcohol Dependence. 38:1995;11-18
34. Simpson D.D., Joe G.W., Rowan-Szal G.A. Drug abuse treatment retention and process effects on follow-up outcomes. Drug and Alcohol Dependence. 47:1997;227-235
35. Stapleton J.M., Morgan M.J., Phillips R.L., Wong D.F., Yung B.C., Shaya E.K., Dannals R.F., Liu X., Grayson R.L., London E.D. Cerebral glucose utilization in polysubstance abuse. Neuropsychopharmacology. 13:1995;21-31
36. Teicher M.H., Anderson C.M., Polcari A., Glod C.A., Maas L.C., Renshaw P.F. Functional deficits in basal ganglia of children with attention-deficit/ hyperactivity disorder shown with functional magnetic resonance imaging relaxometry. Nature Medicine. 6:2000;470-473
37. 31P MRS: absolute concentrations, signal-to-noise and prior knowledge. NMR in Biomedicine. 8:1995;87-93
38. van Zijl P.C., Eleff S.M., Ulatowski J.A., Oja J.M., Ulug A.M., Traystman R.J., Kauppinen R.A. Quantitative assessment of blood flow, blood volume and blood oxygenation effects in functional magnetic resonance imaging. Nature Medicine. 4:1998;159-167
39. Volkow N.D., Fowler J.S., Wolf A.P., Hitzemann R., Dewey S., Bendriem B., Alpert R., Hoff A. Changes in brain glucose metabolism in cocaine dependence and withdrawal. American Journal of Psychiatry. 148:1991;621-626
40. White W.J., Zagon I.S. Acute and chronic methadone exposure in adult rats: studies on arterial blood gas concentrations and pH. Journal of Pharmacology and Experimental Therapeutics. 209:1979;451-455
41. Wyss M., Smeitink J., Wevers R.A., Wallimann T. Mitochondrial creatine kinase: a key enzyme of aerobic energy metabolism. Biochimica et Biophysica Acta. 1102:1992;119-166